Method for cycle detection in sparse, irregularly sampled, long-term neuro-behavioral timeseries: Basis pursuit denoising with polynomial detrending of long-term, inter-ictal epileptiform activity
Numerous physiological processes are cyclical, but sampling these processes densely enough to perform frequency decomposition and subsequent analyses can be challenging. Mathematical approaches for decomposition and reconstruction of sparsely and irregularly sampled signals are well established but...
Saved in:
Published in | PLoS computational biology Vol. 20; no. 4; p. e1011152 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
01.04.2024
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Numerous physiological processes are cyclical, but sampling these processes densely enough to perform frequency decomposition and subsequent analyses can be challenging. Mathematical approaches for decomposition and reconstruction of sparsely and irregularly sampled signals are well established but have been under-utilized in physiological applications. We developed a basis pursuit denoising with polynomial detrending (BPWP) model that recovers oscillations and trends from sparse and irregularly sampled timeseries. We validated this model on a unique dataset of long-term inter-ictal epileptiform discharge (IED) rates from human hippocampus recorded with a novel investigational device with continuous local field potential sensing. IED rates have well established circadian and multiday cycles related to sleep, wakefulness, and seizure clusters. Given sparse and irregular samples of IED rates from multi-month intracranial EEG recordings from ambulatory humans, we used BPWP to compute narrowband spectral power and polynomial trend coefficients and identify IED rate cycles in three subjects. In select cases, we propose that random and irregular sampling may be leveraged for frequency decomposition of physiological signals.
Trial Registration:
NCT03946618
. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 I have read the journal’s policy and the authors of the manuscript have the following competing interests: IB has received compensation from an internship with Cadence Neuroscience Inc., for work unrelated to the current publication. FM has received salary support from Cadence Neuroscience Inc. PEC has received research grant support from Neuronetics, Inc.; NeoSync, Inc; and Pfizer, Inc. PEC has received grant-in-kind (equipment support for investigator-initiated research studies) from Assurex; MagVenture, Inc; and Neuronetics, Inc. He has served on advisory boards for Engrail Therapeutics, Myriad Neuroscience, Procter & Gamble, Sunovion, and Meta Platforms. JVG, GAW, BNL, and BHB are named inventors for intellectual property licensed to Cadence Neuroscience Inc. BNL, JVG, GAW, and NG are investigators for the Medtronic EPAS trial, SLATE trial, and Mayo Clinic Medtronic NIH Public Private Partnership (UH3-NS95495), also with consulting contract. JVG and GAW own stock and have consulting contracts with Neuro-One Inc. JVG is the site primary investigator in the Polyganics ENCASE II trial, NXDC Gleolan Men301 trial, and the Insightec MRgUS EP001 trail. JT has royalty bearing intellectual property agreements with General Electric Healthcare, Shenzhen Mindray Bio-Electric Corp, and Sonoscape Medical Corp. NMG is consulting for NeuroOne (money to Mayo Clinic). |
ISSN: | 1553-7358 1553-734X 1553-7358 |
DOI: | 10.1371/journal.pcbi.1011152 |